NCT02670850

Intervention Program for Patients With Mild Cognitive Impairment

Completed NA Last updated 3 February 2017

What this trial tests

NA trial testing Family Caregiver Intervention Program in Mild Cognitive Impairment in 60 participants. Completed in 31 July 2016.

Timeline

1 August 2013

Primary endpoint
31 July 2016

31 July 2016

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	60
Start date	1 August 2013
Primary completion	31 July 2016
Estimated completion	31 July 2016
Sites	1 location across Taiwan

Drugs / interventions tested

• Family Caregiver Intervention Program

Conditions studied

• Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Chang Gung Memorial Hospital

Who can join

65 and older, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mild Cognitive Impairment (MCI) is a syndrome defined as a cognitive decline that is more severe than can be explained by an individual's age and education. One study in the United States found that MCI caregivers have experienced distress in association with caregiver burden. The prevalence of MCI for people age 65 and older ranges from 3% to 19%. Understanding the process of family caregiving provides a knowledge base for the health professionals when developing effective interventions. However, little is known about the phenomenon of family caregiving to patients with MCI in Taiwan.

Therefore, the purpose of the proposed study is to develop a theoretical model and a model-based intervention program for family caregivers of patients with MCI in Taiwan, and pilot test it in a clinical trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.